|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Investments | |||||||||
| Fixed maturity securities, available for sale, at fair value (amortized cost of $1,593,861 and $1,364,228, respectively) | |||||||||
| Short-term investments, at amortized cost, which approximates fair value | |||||||||
| Total investments | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash and cash equivalents | |||||||||
| Accrued investment income | |||||||||
| Premium balances receivable | |||||||||
| Reinsurance recoverable, net | |||||||||
| Prepaid reinsurance premiums | |||||||||
| Deferred policy acquisition costs | |||||||||
| Property and equipment, net | |||||||||
| Income taxes receivable | |||||||||
| Deferred tax assets, net | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| Liabilities | |||||||||
| Reserve for losses and loss adjustment expenses | |||||||||
| Unearned premiums | |||||||||
| Reinsurance balances payable | |||||||||
| Debt | |||||||||
| Income taxes payable | |||||||||
| Accrued expenses | |||||||||
| Other liabilities | |||||||||
| Total liabilities | |||||||||
| Mezzanine equity | |||||||||
| Performance stock units | |||||||||
| Stockholders' equity | |||||||||
| Common stock | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive (loss) income | |||||||||
| Retained earnings | |||||||||
| Total stockholders' equity | |||||||||
| Total mezzanine equity and stockholders' equity | |||||||||
| Total liabilities, mezzanine equity and stockholders' equity |
Loading...
